Featuring perspectives from Dr Rachel N Grisham, including the following topics:
Case: A woman in her early 40s with recurrent low-grade serous ovarian cancer (LGSOC) and prior treatment with a MEK inhibitor receives avutometinib/defactinib on the RAMP 301 trial (0:00)
Case: A woman in her early 70s with recurrent KRAS-mutated LGSOC receives avutometinib/defactinib and develops muscle weakness (10:03)
Case: A woman in her late 70s with KRAS-mutated recurrent LGSOC develops congestive heart failure on trametinib and then receives avutometinib/defactinib (16:15)
Case: A woman in her mid 60s with recurrent BRAF V600E LGSOC has concerns about side effects and receives single-agent dabrafenib (19:49)
34.Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
00:20:03
33.TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting
00:54:44
32.For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress
01:30:19
31.Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
01:29:56
30.Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
02:01:19
29.Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
00:15:08
28.Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
00:11:22
27.Endometrial Cancer — An Interview with Dr Floor J Backes
00:56:04
26.For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
01:28:54
25.For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
01:28:12
24.Ovarian Cancer — Fifth Annual National General Medical Oncology Summit
00:54:27
23.HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
01:27:59
22.Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
01:31:15
21.Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
01:28:26
20.Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
01:29:32
19.Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
00:55:38
18.Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting
00:57:09
17.Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore
00:54:56
16.Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
00:48:48
15.Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases
01:00:17
14.Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
00:52:34
13.Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances
00:59:34
12.Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches
00:53:51
11.Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
01:59:44
10.For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress
01:31:26
9.For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress
01:28:46
8.Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit
00:48:41
7.Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
01:29:32
6.HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
01:29:20
5.Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers
00:46:41
4.Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
00:52:36
3.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
00:59:17
2.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
00:59:53
1.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
01:01:36
11.Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
01:05:36
10.Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
01:01:24
9.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
01:03:54
8.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
01:02:10
7.Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer
00:21:39
6.Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
00:43:12
5.Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
00:57:26
4.The Implications of New Research Findings for the Management of Endometrial Cancer
01:01:16
3.Recent Advances and Future Directions in Gynecologic Cancers — With Dr Michael Birrer and Ursula Matulonis (Proceedings from a Symposium in Partnership with NCOA and SCOS)
01:03:43
2.Oncology Today with Dr Neil Love: Management of Desmoid Tumors
00:54:24
1.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
01:03:52
4.Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer
00:50:05
3.Consensus or Controversy? Current and Future Management of Ovarian Cancer
01:03:03
1.The Clinical Implications of Key Recent Data Sets in Endometrial Cancer — With Dr Shannon Westin (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)
00:22:26
2.The Clinical Implications of Key Recent Data Sets in Ovarian Cancer — With Dr David O’Malley (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)